AAAAAA
Results: 1-25/71
Authors:
Skyler, JS
Citation: Js. Skyler, Diabetes Reviews says goodbye, DIABET REV, 7(4), 1999, pp. 233-234
Authors:
Boulton, AJM
Citation: Ajm. Boulton, Neuropathy and diabetes - Introduction, DIABET REV, 7(4), 1999, pp. 235-236
Authors:
Boulton, AJM
Gries, FA
Jervell, JA
Citation: Ajm. Boulton et al., Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy (Reprinted from Diabet Med, vol 15, pg 508-514, 1998), DIABET REV, 7(4), 1999, pp. 237-244
Authors:
Shaw, JE
Zimmet, PZ
Citation: Je. Shaw et Pz. Zimmet, The epidemiology of diabetic neuropathy, DIABET REV, 7(4), 1999, pp. 245-252
Authors:
Malik, RA
Citation: Ra. Malik, Pathology and pathogenesis of diabetic neuropathy, DIABET REV, 7(4), 1999, pp. 253-260
Authors:
Rayman, G
Citation: G. Rayman, Diabetic neuropathy and microcirculation, DIABET REV, 7(4), 1999, pp. 261-274
Authors:
Carrington, AL
Litchfield, JE
Citation: Al. Carrington et Je. Litchfield, The aldose reductase pathway and nonenzymatic glycation in the pathogenesis of diabetic neuropathy: a critical review for the end of the 20th century, DIABET REV, 7(4), 1999, pp. 275-299
Authors:
Fernyhough, P
Tomlinson, DR
Citation: P. Fernyhough et Dr. Tomlinson, The therapeutic potential of neurotrophins for the treatment of diabetic neuropathy, DIABET REV, 7(4), 1999, pp. 300-311
Authors:
Eaton, S
Tesfaye, S
Citation: S. Eaton et S. Tesfaye, Clinical manifestations and measurement of somatic neuropathy, DIABET REV, 7(4), 1999, pp. 312-325
Authors:
Andersen, H
Jakobsen, J
Citation: H. Andersen et J. Jakobsen, Motor function in diabetes, DIABET REV, 7(4), 1999, pp. 326-341
Authors:
Ziegler, D
Citation: D. Ziegler, Cardiovascular autonomic neuropathy: clinical manifestations and measurement, DIABET REV, 7(4), 1999, pp. 342-357
Authors:
Vinik, A
Erbas, T
Stansberry, K
Citation: A. Vinik et al., Gastrointestinal, genitourinary, and neurovascular disturbances in diabetes, DIABET REV, 7(4), 1999, pp. 358-378
Authors:
Boulton, AJM
Citation: Ajm. Boulton, Current and emerging treatments for the diabetic neuropathies, DIABET REV, 7(4), 1999, pp. 379-386
Authors:
Vileikyte, L
Citation: L. Vileikyte, Psychological aspects of diabetic peripheral neuropathy, DIABET REV, 7(4), 1999, pp. 387-394
Authors:
Jude, EB
Boulton, AJM
Citation: Eb. Jude et Ajm. Boulton, End-stage complications of diabetic neuropathy, DIABET REV, 7(4), 1999, pp. 395-410
Authors:
Lebovitz, HE
Citation: He. Lebovitz, Insulin secretagogues: old and new, DIABET REV, 7(3), 1999, pp. 139-153
Authors:
Naik, RG
Palmer, JP
Citation: Rg. Naik et Jp. Palmer, Preservation of beta-cell function in type 1 diabetes, DIABET REV, 7(3), 1999, pp. 154-182
Authors:
Kenyon, NS
Kenyon, NM
Ricordi, C
Citation: Ns. Kenyon et al., Nonhuman primate models of islet transplantation: preclinical testing of novel immunotherapies, DIABET REV, 7(3), 1999, pp. 183-186
Authors:
Christiansen, E
Citation: E. Christiansen, Metabolic consequences of successful simultaneous pancreas kidney transplantation in humans, DIABET REV, 7(3), 1999, pp. 187-216
Authors:
Larner, J
Huang, LC
Citation: J. Larner et Lc. Huang, Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G-proteins, DIABET REV, 7(3), 1999, pp. 217-231
Authors:
Saleh, YM
Mudaliar, SR
Henry, RR
Citation: Ym. Saleh et al., Metabolic and vascular effects of the thiazolidinedione troglitazone, DIABET REV, 7(2), 1999, pp. 55-76
Authors:
Scheen, AJ
Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Management of the obese diabetic patient, DIABET REV, 7(2), 1999, pp. 77-93
Authors:
Bailey, CJ
Citation: Cj. Bailey, New pharmacological approaches to glycemic control, DIABET REV, 7(2), 1999, pp. 94-113
Authors:
Shafrir, E
Ben-Sasson, R
Ziv, E
Bar-On, H
Citation: E. Shafrir et al., Insulin resistance beta-cell survival, and apoptosis in type 2 diabetes: animal models and human implications, DIABET REV, 7(2), 1999, pp. 114-123
Authors:
Leibowitz, G
Levine, F
Citation: G. Leibowitz et F. Levine, Gene therapy for type 1 and type 2 diabetes, DIABET REV, 7(2), 1999, pp. 124-138